Testicular Tuberculosis after Intravesical BCG for Urinary Bladder Cancer: A Role of FDG PET-CT
Year: 2024
Type: article
Study design: Case Report
Abstract: Bacillus Calmette–Guërin (BCG) has been traditionally used as a vaccine against tuberculosis (TB), which contains live, attenuated strain of Mycobacterium bovis . However, intravesical BCG administration has been used as an immunological treatment of superficial bladder cancer. Complications after bladder instillation of BCG are rare. We report a case of carcinoma urinary bladder with histopathologically proven granulomatous epididymo-orchitis (TB) after treatment with intravesical BCG.
Authors: R Arun Visakh, Senthil Raja, Thara Pratap, Renu Mariam Thomas, Vadavattathu Padmanabhan Gangadharan
Institution: Lakeshore Hospital
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
OpenAlex ID: W4408655994